UNSPSC 51292005: Clorgiline

This classification denotes a monoamine oxidase inhibitor with the molecular formula C13H15Cl2NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LYJ16FZU9Q, chemically known as 2-propynylamine, n-(3-(2,4-dichlorophenoxy)propyl)-n-methyl- but generally known as clorgiline, which bears US NIH Compound Identifier 4380. European Medicines Agency schedules Clorgiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06755MIG.

UNSPSC 51292005 Clorgiline is a Commodity code that encompasses pharmaceutical products used in emergency medical and public health interventions. State and local governments procuring under this code are buying naloxone (opioid antagonist) and drug deactivation systems to support community health and overdose-response initiatives. The issuing bodies soliciting under this code include county health departments and public health agencies managing emergency medical supplies and harm-reduction programs.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option and is potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act. Bidders must provide unit costs, maintain workers' compensation and commercial general liability insurance, complete E-Verify verification, and accept a three-month probationary period. The available recent-opportunities block shows limited current activity under this code; the single opportunity reflects county-level procurement for emergency medical supplies in Florida.